CINV Flashcards

1
Q

What are the risk factors for CINV?
(You Find Happy People Holding Love Always, YFHPHLA)

A
  1. Younger age (< 50 y/o)
  2. Females
  3. Hx of emesis during pregnancy
  4. Prone to motion sickness
  5. Hx of CINV
  6. Little or no previous alcohol intake (<1 glass/ day)
  7. Anxiety/ high pretreatment expectation of nausea
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Name the 5HT3 antagonists.

What is their MOA?

A

Ondansetron, Granisetron, Palonosetron

Block serotonin receptors peripherally in the GI tract and centrally in the medulla

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

ADEs of 5HT3 antagonists?

A
  • Headache
  • Constipation (counsel on mgmt)

(may also increase LFTs and cause QTc prolongation)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the ADEs of dexamethasone?

A
  • Incr in blood glucose levels
  • Insomnia
  • Anxiety
  • Gastric upset

(less common: psychosis, reactivation of ulcers)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is the MOA of NK1 receptor antagonists?

A

Binds to NK1 receptor and blocks substance P from binding. Attenuates vagal afferent signals and exerts antiemetic effects.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the ADEs of NK1 receptor antagonists?

A
  • Fatigue
  • Weakness
  • Hiccups
  • Nausea
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the drug-drug interactions of NK1 receptor antagonists?

A

Steroids:
- May increase AUC of dexamethasone

Oral contraceptives:
- May reduce effectiveness. Recommend another form of birth control for women of childbearing age

Warfarin:
- May decrease INR. Check pt’s INR within 7-10 days of giving NK1 antagonists

BZDs:
- Increase concentration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are the ADEs of Akynzeo tablet (Netupitant + Palonosetron)?

A
  • Headache
  • Weakness
  • Dyspepsia
  • Fatigue
  • Constipation
  • Erythema
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

MOA of metoclopramide (dopamine antagonist)?

A

Main:
- Blocks dopamine receptors in CTZ (central)
- Blocks 5HT3 receptors in gut (peripheral)

Others:
- Stimulates cholinergic activity in gut
- Increases gut motility

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are the ADEs of metoclopramide (dopamine antagonist)?

A
  • Mild sedation
  • Diarrhea
  • EPSE (dystonia, akathisia), which can be mitigated by diphenhydramine/ benztropine
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What drug MUST we AVOID with metoclopramide and why?

A

AVOID metoclopramide and olanzapine due to increased risk of EPSEs, neuroleptic malignant syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are adjunctive agents for refractory CINV?

What are their MOAs?

A
  • Phenothiazines (prochlorperazine, chlorpromazine, promethazine)
  • Butyrophenones (haloperidol)

MOA: block dopamine receptors in CTZ

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Dosing of phenothiazines (prochlorperazine)?

A

PO 10mg TDS/ QDS PRN

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Dosing of Butyrophenones (haloperidol)?

A

PO/IV 0.5-2mg Q4-6H

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

ADEs of phenothiazines (prochlorperazine, chlorpromazine, promethazine)?

A
  • Drowsiness
  • Hypotension
  • Akathisia
  • Dystonia
  • EPSE
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

ADEs of Butyrophenones (haloperidol)?

A
  • Sedation
  • EPSE
17
Q

What is the choice of drug for anticipatory CINV/ breakthrough CINV with anxiety component?

A

Benzodiazepines (Lorazepam)

18
Q

What are the dosings of BZDs?

A

PO alprazolam 0.5-1mg
PO lorazepam 0.5-2mg

give the night BEFORE chemoTx and 1-2h BEFORE chemoTx

19
Q

ADEs of Benzodiazepines (Lorazepam)?

A
  • Drowsiness
  • Dizziness
  • Hypotension
  • Anterograde amnesia (which helps with the anticipatory CINV)
  • Urinary incontinence
  • Paradoxical reactions (hyperactive, aggressive behaviour)
20
Q

MOA of Olanzapine (atypical antipsychotic)?

A

Blocks multiple neurotransmitters including dopamine, serotonin, catecholamines, acetylcholine, histamine

21
Q

ADEs of Olanzapine (atypical antipsychotic)?

Why do we need to use with caution in older adults?

A
  • Sedation
  • Dry mouth
  • Increased appetite
  • Weight gain
  • Postural hypotension
  • QTc prolongation
  • Dizziness
  • A/w elevated risk of hyperlipidemia, hyperglycemia, and new-onset diabetes. Caution in older adults due to incr risk of death and dementia-related psychosis
22
Q

What are the general principles of breakthrough CINV?

A
  • Give different classes of drug to target other MOAs
  • If PO not feasible due to ongoing vomiting, try IV/ rectal route
  • Hydration and fluid repletion for losses
23
Q

What are some non-pharmacoTx for CINV?

A
  1. Small, frequent meals. Avoid heavy meals
  2. Avoid greasy, spicy, very sweet/ salty foods, foods with strong flavours/ smells
  3. Sucking on candy
  4. Sip small amounts of fluids instead of drinking one full glass
  5. Avoid caffeinated beverages
  6. Avoid lying flat 2h after eating
24
Q

What are multi-day regimens?

A

Prophylactic Tx for expected emetogenicity on each day of chemoTx (most emetogenic risk drug) + cover delayed prophylaxis for 2-3 days after chemoTx completed